# RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

> **NCT06195540** · PHASE3 · RECRUITING · sponsor: **University Hospital, Angers** · enrollment: 1424 (estimated)

## Conditions studied

- Venous Thromboembolism
- Deep Vein Thrombosis
- Pulmonary Embolism
- Lower Limb Trauma
- Thromboprophylaxis
- Immobilisation

## Interventions

- **DRUG:** Rivaroxaban 10 MG
- **DRUG:** Low Heparin Molecular Weight

## Key facts

- **NCT ID:** NCT06195540
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-19
- **Primary completion:** 2026-11-19
- **Final completion:** 2026-11-19
- **Target enrollment:** 1424 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06195540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06195540, "RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06195540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*